Lowest Price Guaranteed
Slides
Not Available
Last Updated
September 2023
View Count
11336
1. Market Overview
2. Dashboard: Pipeline and Trial Analysis
3. CAR-T Clinical Development: Trial Details
4. TCR Clinical Development: Trial Details
5. TIL Clinical Development: Trial Details
6. Market Forecast: Assumptions
7. Market Forecast, 2015-2030
8. Preclinical Development
9. Inclusion / Exclusion Criteria
10. Abbreviations
Pipeline and Trial Details
Figure 1 T-cell Immunotherapy Products in Clinical Development: Distribution by Type of Therapy
Figure 2 T-cell Immunotherapy Trialsin Clinical Development: Distribution by Type of Therapy
Figure 3 T-cell Immunotherapy Products in Clinical Development: Distribution by Phase of Development
Figure 4 T-cell Immunotherapy Products in Clinical Development: Distribution by Phase of Development and Type of Therapy
Figure 5 T-cell Immunotherapy Products in Clinical Development: Distribution by Therapeutic Area
Figure 6 T-cell Immunotherapy Products in Clinical Development: Distribution by Therapeutic Area and Type of Therapy
Figure 7 T-cell Immunotherapy Products in Clinical Development: Distribution by Target in the CAR-T Market
Figure 8 T-cell Immunotherapy Products in Clinical Development: Distribution by Targets in the TCR Market
Figure 9 T-cell Immunotherapy Products in Clinical Development: Distribution by Industrial Developers for CAR-T Therapy
Figure 10 T-cell Immunotherapy Products in Clinical Development: Distribution by Industrial Developers for TCR Therapy
Figure 11 T-cell Immunotherapy Trials in Clinical Development: Distribution by Phase of Development
Figure 12 T-cell Immunotherapy Trials in Clinical Development: Distribution by Phase of Development and Type of Therapy
Figure 13 T-cell Immunotherapy Trials in Clinical Development: Distribution by Therapeutic Area
Figure 14 T-cell Immunotherapy Trials in Clinical Development: Distribution by Therapeutic Area and Type of Therapy
Figure 15 T-cell Immunotherapy Trials in Clinical Development: Distribution by Trial Status
Figure 16 T-cell Immunotherapy Trials in Clinical Development: Distribution by Trial Status and Type of Therapy
Figure 17 T-cell Immunotherapy Trials in Clinical Development: Distribution by Sponsorship
Figure 18 T-cell Immunotherapy Trials in Clinical Development: Distribution by Sponsorship and Type of Therapy
Figure 19 T-cell Immunotherapy Trials in Clinical Development: Distribution by Region
Figure 20 T-cell Immunotherapy Trials in Clinical Development: Distribution by Region and Type of Therapy
Figure 21 T-cell Immunotherapy Trials in Clinical Development: Distribution by G7 Countries
Figure 22 T-cell Immunotherapy Trials in Clinical Development: Distribution by G7 Countries and Type of Therapy
Market Forecast Analysis
Figure A T-cell Immunotherapy Market Forecast, 2015-2030
Figure B T-cell Immunotherapy Market, Share of Sub-segments: Base Scenario 2020, 2025 and 2030 (USD Million
Pipeline Details
Table 1 CAR-T Clinical Development: Pipeline Details
Table 2 TCR Clinical Development: Pipeline Details
Table 3 TIL Clinical Development: Pipeline Details
Table 4 Preclinical Development
Market Forecast Analysis
Table A Market Forecast: Assumptions
The following companies and organisations have been mentioned in the report: